Prostate Cancer Therapy
New prostate cancer therapy study results reported from University of Texas, Comprehensive Cancer Center
Published in Cancer Weekly, January 27th, 2009
Investigators publish new data in the report 'Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.' "beta-Lapachone (ARQ 501, a formulation of beta-lapachone complexed with hydroxypropyl-beta-cyclodextrin) is a novel anticancer agent with selectivity against prostate cancer cells overexpressing the NAD(P)H:quinone oxidoreductase-1 enzyme. Lack of solubility and an efficient drug delivery strategy limits this compound in clinical applications," scientists writing in the journal Clinical Cancer Research report.
"In this study, we aimed to develop beta-lapachone-containing polymer implants (millirods) for direct implantation into...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-01-27)
More Articles from Cancer Weekly
- Cedars-Sinai Medical Center
Gene therapy eliminates brain tumors through selective recruitment of immune cells - Advaxis, Incorporated
Advaxis Prevails in European Patent Court - Aegis Health Group
Hospital-Employer Partnerships Growing as Employers Seek Ways to Improve Health and Manage Dollars in Tough Economic Times - Brain Cancer
New research on brain cancer from Brain Tumor Center summarized - Cancer
Cancer as a Crucible: the Story of a Teenage Immigrant Who Survived Cancer and Built a New Life for Herself - Cancer Gene Therapy
Gene Marker May Improve Odds of Stem Cell Therapies for Disease - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
